Formoterol for acute asthma in the emergency department: a systematic review with meta-analysis

Annals of Allergy, Asthma and Immunology

Volumn 104, Issue 3, 2010, Pages 247-252

  Rodrigo, Gustavo J ^a   Neffen, Hugo ^b   Colodenco, Federico D ^c   Castro Rodriguez, José A ^d  

^a HOSPITAL CENTRAL DE LAS FUERZAS ARMADAS   (Uruguay)

^b 'O Alassia' Children's Hospital   (Argentina)

^c Directora del departamento de EPID   (Argentina)

^d PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; FORMOTEROL; FORMOTEROL FUMARATE; POTASSIUM; SALBUTAMOL; SHORT ACTING BETA 2 AGONIST; TERBUTALINE; UNCLASSIFIED DRUG;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; ASTHMATIC STATE; CHILD; CLINICAL EVALUATION; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERANCE; ELECTROCARDIOGRAPHY; EMBASE; EMERGENCY CARE; EMERGENCY WARD; FEMALE; FORCED EXPIRATORY VOLUME; HEART RATE; HOSPITALIZATION; HUMAN; INFORMATION RETRIEVAL; MAJOR CLINICAL STUDY; MALE; MEDLINE; META ANALYSIS; MULTICENTER STUDY; MULTIPLE DRUG DOSE; OUTCOME ASSESSMENT; PATIENT SAFETY; PEAK EXPIRATORY FLOW; POTASSIUM BLOOD LEVEL; PRESCHOOL CHILD; PRIORITY JOURNAL; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL; REPEATED DRUG DOSE; SCHOOL CHILD; SINGLE DRUG DOSE; SPIROMETRY; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ASTHMA; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; EMERGENCIES; EMERGENCY SERVICE, HOSPITAL; ETHANOLAMINES; FEMALE; HUMANS; INHALATION; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 77649117408     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2009.11.064     Document Type: Article

References (22)

1. Rodrigo G.J., Rodrigo C., and Hall J.B. Acute asthma in adults: a review. Chest 125 (2004) 1091-1102
2. Rodrigo G.J., and Castro-Rodriguez J. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax 60 (2005) 740-746
3. Najafizadeh K., Sohrab Pour H., Ghadyanee M., Shiehmorteza M., Jamali M., and Maidzadeh S. A randomized, double-blind, placebo-controlled study to evaluate the role of formoterol in the management of acute asthma. Emerg Med J 24 (2007) 317-321
4. Lee-Wong M., Chou V., and Ogawa Y. Formoterol fumarate inhalation powder vs. albuterol nebulizer for the treatment of asthma in the acute care setting. Ann Allergy Asthma Immunol 100 (2008) 146-152
5. Ringdal N., Derom E., Wahlin-Boll E., and Pauwels R. Onset and duration of action of single doses of formoterol inhaled via Turbuhaler. Respir Med 92 (1998) 1017-1021
6. Seberová E., and Andersson A. Oxis (formoterol given by Turbuhaler) showed as rapid an onset of action as salbutamol given by a pMDI. Respir Med 94 (2000) 607-611
7. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention: Revised 2008. http://www:ginasthma.com Accessed July 29, 2009
8. PRISMA. Transparent reporting of systematic reviews and meta-analyses. http://www.prisma-statement.org/index.htm Accessed July 22, 2009
9. Higgins J.P.T., and Altman D.G. Chapter 8: assessing risk of bias in included studies. In: Higgins J.P.T., and Green S. (Eds). Cochrane Handbook for Systematic Reviews of Interventions, Version 5.0.1 (updated September 2008), The Cochrane Collaboration. http://www.cochrane-handbook.org Accessed June 26, 2009
10. Higgins J.P.T., Thompson S.G., Deecks J.J., and Altman D.G. Measuring inconsistency in meta-analyses. BMJ 327 (2003) 557-560
11. Borenstein M., Hedges L.V., Higgins J.P.T., and Rothstein H.R. Introduction to Meta-analysis (2009), John Wiley & Sons, Chichester (West Sussex), England
12. Egger M., Davey Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
13. Altman D.G., and Bland J.M. Interaction revisited: the difference between two estimates. BMJ 326 (2003) 219
14. Malolepszy J., Boszormenyi Nagy G., Selroos O., Larsson P., and Brander R. Safety of formoterol Turbuhaler1 at cumulative dose of 90 mg in patients with acute bronchial obstruction. Eur Respir J 18 (2001) 928-934
15. Boonswat W., Charoenratanakul S., Pothirat C., et al. Formoterol (Oxys) Turbuhaler as a rescue therapy compared with salbutamol pMDI plus spacer in patients with acute severe asthma. Respir Med 97 (2003) 1067-1074
16. Avila-Castañón L., Casas-Becerra B., Del Río-Navarro B.E., Velázquez-Armenta Y., and Sienra-Monge J.J. Formoterol vs albuterol administered via Turbuhaler system in the emergency treatment of acute asthma in children. Allergol Immunopathol (Madr) 32 (2004) 18-20
17. Balanag V.M., Yunus F., Yang P.C., and Jorup C. Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma. [published online ahead of print July 11, 2005]. Pulm Pharmacol Ther 19 (2006) 139-147
18. Rubinfeld A.R., Scicchitano R., Hunt A., Thompson P.J., Van Nooten A., and Selroose O. Formoterol Turbuhaler as reliever medication in patients with acute asthma. Eur Respir J 27 (2006) 735-741
19. Rodriguez E., Vera V., Perez-Puigbo A., et al. Equivalence of a single saline nebulised dose of formoterol powder vs three doses of nebulised Albuterol every twenty minutes in acute asthma in children: a suitable cost effective approach for developing nations. Allergol Immunopathol (Madr) 36 (2008) 196-200
20. Bussamra M.H., Stelmach R., Rodrigues J.C., and Cukier A. A randomized, comparative study of formoterol and terbutaline dry powder inhalers in the treatment of mild to moderate asthma exacerbations in the pediatric acute care setting. Ann Allergy Asthma Immunol 103 (2009) 248-253
21. Rosenborg J., Bengtsson T., Larsson P., Blomgren A., Persson G., and Lötvall J. Relative systemic dose potency and tolerability of inhaled formoterol and salbutamol in healthy subjects and asthmatics. Eur J Clin Pharmacol 56 (2000) 363-370
22. Rosenborg J., Larsson P., Rott Z., Böcskei C., Poczi M., and Juhász G. Relative therapeutic index between inhaled formoterol and salbutamol in asthma patients. Respir Med 96 (2002) 412-417